According to the introduction, this PCV vaccine independently developed by China could create direct economic benefits of over one billion yuan and reduce the loss from the disease by over 36 billion yuan during the four years’ protection period, and help the swine industry save vaccination expenses of three billion yuan each year.
http://english.agri.gov.cn/ga/news/201011/t20101105_2574.htm